| Name | LY3437943 | CAS# | 2381089-83-2 | |
|---|---|---|---|---|
| Price | ¥Inquiry/1kg ¥Inquiry/1g ¥Inquiry/1mg ¥Inquiry/1ton | Purity | 99.0% | |
| Stocking Period |
1 Day | Stock | In Stock | |
| Product Webpage: | https://peptidee.com/index.php/product/retatrutide/ | |||
| Detail
Product Information
Retatrutide Overview Retatrutide, with its compound code LY-3437943, is an experimental peptide drug targeting obesity. It functions as a triple hormone receptor agonist, influencing metabolic regulation and appetite control. Notably effective in weight reduction, it’s a pioneering approach in obesity management, offering potential improvements in metabolic health. Product Details Structure:Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg Molecular Formula:C101H152N28O22S2 Molecular Weight:64 g/mol PubChem SID:255386757 CAS Number:1627580-64-6 Synonyms:Mitochondrial open reading frame of the 12S rRNA-c, MT-RNR1 Research Highlights Retatrutide & Weight Loss:In a phase 2 trial, participants saw a mean weight reduction of 18% at 24 weeks and 24% at 48 weeks, surpassing placebo results. Retatrutide & Glucose Metabolism:As a triple agonist, it positively influences glucose metabolism, beneficial in managing obesity-related impaired glucose regulation. Retatrutide & Dose Response:The trial demonstrated a dose-response relationship, with higher doses leading to greater weight reduction, highlighting its customizable potential for obesity treatment. Important Notices: This product is sold for scientific research purposes only. |